Selected research
Market Outlook & Growth Opportunities
Global ChIP Sequencing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global ChIP Sequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for ChIP Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for ChIP Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for ChIP Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the ChIP Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the ChIP Sequencing Service market include Illumina, BGI, Creative Biolabs, Thermo Fisher Scientific, Eurofins Genomics, Diagenode, Merck, Agilent and Zymo Research, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global ChIP Sequencing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of ChIP Sequencing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents ChIP Sequencing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global ChIP Sequencing Service market.
ChIP Sequencing Service Segment by Company
Illumina
BGI
Creative Biolabs
Thermo Fisher Scientific
Eurofins Genomics
Diagenode
Merck
Agilent
Zymo Research
Chromatrap
Active Motif
ChIP Sequencing Service Segment by Type
X-ChIP
N-ChIP
ChIP Sequencing Service Segment by Application
Transcription Factor
Histone Modification and Variant Histones
Other
ChIP Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global ChIP Sequencing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the ChIP Sequencing Service key companies, revenue, market share, and recent developments.
3. To split the ChIP Sequencing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions ChIP Sequencing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify ChIP Sequencing Service significant trends, drivers, influence factors in global and regions.
6. To analyze ChIP Sequencing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ChIP Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of ChIP Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ChIP Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global ChIP Sequencing Service industry.
Chapter 3: Detailed analysis of ChIP Sequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of ChIP Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of ChIP Sequencing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- X-ChIP
- N-ChIP
Applications
- Transcription Factor
- Histone Modification and Variant Histones
- Other
Companies covered
- Illumina
- BGI
- Creative Biolabs
- Thermo Fisher Scientific
- Eurofins Genomics
- Diagenode
- Merck
- Agilent
- Zymo Research
- Chromatrap
- Active Motif
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global ChIP Sequencing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global ChIP Sequencing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 ChIP Sequencing Service Market Dynamics
- 2.1 ChIP Sequencing Service Industry Trends
- 2.2 ChIP Sequencing Service Industry Drivers
- 2.3 ChIP Sequencing Service Industry Opportunities and Challenges
- 2.4 ChIP Sequencing Service Industry Restraints
3 ChIP Sequencing Service Market by Company
- 3.1 Global ChIP Sequencing Service Company Revenue Ranking in 2025
- 3.2 Global ChIP Sequencing Service Revenue by Company (2021-2026)
- 3.3 Global ChIP Sequencing Service Company Ranking (2024-2026)
- 3.4 Global ChIP Sequencing Service Company Manufacturing Base and Headquarters
- 3.5 Global ChIP Sequencing Service Company Product Type and Application
- 3.6 Global ChIP Sequencing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global ChIP Sequencing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 ChIP Sequencing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 ChIP Sequencing Service Market by Type
- 4.1 ChIP Sequencing Service Type Introduction
- 4.1.1 X-ChIP
- 4.1.2 N-ChIP
- 4.2 Global ChIP Sequencing Service Sales Value by Type
- 4.2.1 Global ChIP Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global ChIP Sequencing Service Sales Value by Type (2021-2032)
- 4.2.3 Global ChIP Sequencing Service Sales Value Share by Type (2021-2032)
5 ChIP Sequencing Service Market by Application
- 5.1 ChIP Sequencing Service Application Introduction
- 5.1.1 Transcription Factor
- 5.1.2 Histone Modification and Variant Histones
- 5.1.3 Other
- 5.2 Global ChIP Sequencing Service Sales Value by Application
- 5.2.1 Global ChIP Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global ChIP Sequencing Service Sales Value by Application (2021-2032)
- 5.2.3 Global ChIP Sequencing Service Sales Value Share by Application (2021-2032)
6 ChIP Sequencing Service Regional Value Analysis
- 6.1 Global ChIP Sequencing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global ChIP Sequencing Service Sales Value by Region (2021-2032)
- 6.2.1 Global ChIP Sequencing Service Sales Value by Region: 2021-2026
- 6.2.2 Global ChIP Sequencing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America ChIP Sequencing Service Sales Value (2021-2032)
- 6.3.2 North America ChIP Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe ChIP Sequencing Service Sales Value (2021-2032)
- 6.4.2 Europe ChIP Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific ChIP Sequencing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific ChIP Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America ChIP Sequencing Service Sales Value (2021-2032)
- 6.6.2 South America ChIP Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa ChIP Sequencing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa ChIP Sequencing Service Sales Value Share by Country, 2025 VS 2032
7 ChIP Sequencing Service Country-level Value Analysis
- 7.1 Global ChIP Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global ChIP Sequencing Service Sales Value by Country (2021-2032)
- 7.2.1 Global ChIP Sequencing Service Sales Value by Country (2021-2026)
- 7.2.2 Global ChIP Sequencing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt ChIP Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt ChIP Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt ChIP Sequencing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Illumina
- 8.1.1 Illumina Company Information
- 8.1.2 Illumina Business Overview
- 8.1.3 Illumina ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Illumina ChIP Sequencing Service Product Portfolio
- 8.1.5 Illumina Recent Developments
- 8.2 BGI
- 8.2.1 BGI Company Information
- 8.2.2 BGI Business Overview
- 8.2.3 BGI ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 BGI ChIP Sequencing Service Product Portfolio
- 8.2.5 BGI Recent Developments
- 8.3 Creative Biolabs
- 8.3.1 Creative Biolabs Company Information
- 8.3.2 Creative Biolabs Business Overview
- 8.3.3 Creative Biolabs ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Creative Biolabs ChIP Sequencing Service Product Portfolio
- 8.3.5 Creative Biolabs Recent Developments
- 8.4 Thermo Fisher Scientific
- 8.4.1 Thermo Fisher Scientific Company Information
- 8.4.2 Thermo Fisher Scientific Business Overview
- 8.4.3 Thermo Fisher Scientific ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Thermo Fisher Scientific ChIP Sequencing Service Product Portfolio
- 8.4.5 Thermo Fisher Scientific Recent Developments
- 8.5 Eurofins Genomics
- 8.5.1 Eurofins Genomics Company Information
- 8.5.2 Eurofins Genomics Business Overview
- 8.5.3 Eurofins Genomics ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Eurofins Genomics ChIP Sequencing Service Product Portfolio
- 8.5.5 Eurofins Genomics Recent Developments
- 8.6 Diagenode
- 8.6.1 Diagenode Company Information
- 8.6.2 Diagenode Business Overview
- 8.6.3 Diagenode ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Diagenode ChIP Sequencing Service Product Portfolio
- 8.6.5 Diagenode Recent Developments
- 8.7 Merck
- 8.7.1 Merck Company Information
- 8.7.2 Merck Business Overview
- 8.7.3 Merck ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Merck ChIP Sequencing Service Product Portfolio
- 8.7.5 Merck Recent Developments
- 8.8 Agilent
- 8.8.1 Agilent Company Information
- 8.8.2 Agilent Business Overview
- 8.8.3 Agilent ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Agilent ChIP Sequencing Service Product Portfolio
- 8.8.5 Agilent Recent Developments
- 8.9 Zymo Research
- 8.9.1 Zymo Research Company Information
- 8.9.2 Zymo Research Business Overview
- 8.9.3 Zymo Research ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 Zymo Research ChIP Sequencing Service Product Portfolio
- 8.9.5 Zymo Research Recent Developments
- 8.10 Chromatrap
- 8.10.1 Chromatrap Company Information
- 8.10.2 Chromatrap Business Overview
- 8.10.3 Chromatrap ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Chromatrap ChIP Sequencing Service Product Portfolio
- 8.10.5 Chromatrap Recent Developments
- 8.11 Active Motif
- 8.11.1 Active Motif Company Information
- 8.11.2 Active Motif Business Overview
- 8.11.3 Active Motif ChIP Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Active Motif ChIP Sequencing Service Product Portfolio
- 8.11.5 Active Motif Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst